EGADSS (Evidence-based Guideline and Decision Support System) is an open source tool that is designed to work in conjunction with primary care Electronic Medical Record (EMR) systems to provide patient specific point of care reminders in order to aid physicians provide high quality care. EGADSS is designed as a stand alone system that would respond to requests from existing Electronic Medical Records such as Wolf, Med Access, and MedOffIS to provide patient specific clinical guidance based on its internal collection of guidelines.
You can use the category filters given on the right sidebar to narrow down your search results.
ADDIS is a software developed within the Dutch Escher-project for managing and analyzing clinical trial information.
ADDIS is a proof-of-concept system that allows us to simultaneously discover the possibilities of and the requirements on a database of structured clinical trials data. The automated discovery and (meta-)analysis of trial data, as well as benefit-risk assessment is supported.
ADDIS comes with two built-in examples:
In the last 20 years, researchers have investigated solutions to enable seamless access to online resources within the context of electronic health record (EHR) systems. “Infobuttons” are among these solutions. Based on contextual attributes that describe the EHR user, the patient, and the care setting, infobuttons anticipate clinicians’ information needs and provide automated links to a set of relevant knowledge resources to assist clinical decision support.
The Zambia Electronic Perinatal Record System (ZEPRS) is an Electronic Medical Record (EMR) system used by public obstetric clinics and a hospital (the University Teaching Hospital) in Lusaka, Zambia to improve patient care. The University of Alabama Birmingham (UAB) Center for Research in Women's Health (CRWH), RTI, and the Center for Infectious Disease Research in Zambia (CIDRZ) developed ZEPRS with local medical expertise and project engagement from the Lusaka Urban Health District, Central Board of Health and funding support from the Bill & Melinda Gates Foundation.